Breast: Prevention Clinical Trials

Showing 1-2 of 2 items
1.
2.
  • Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
  • This research study is evaluating the use of Cardiac Magnetic Resonance Imaging (CMR) as a method of detecting early signs of damage to the heart that can be associated with adjuvant therapy of anthracycline (doxorubicin)-based combination chemotherapy followed by treatment with herceptin (trastuzumab for the treatment of (HER+) breast cancer.
  • Diagnoses: Breast: Prevention
  • Status: Recruiting
Showing 1-2 of 2 items
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms